SOLESENCE, INC.
AI Executive Summary
AI-powered analysis of 10-Q filing content
Solésence swung from net income of $3.2M (Q2 2025) to a net loss of $(158)K (Q2 2026), with total revenue declining ~25% YoY, driven by loss of a major customer launch benefit and softening in personal care ingredients. The company disclosed a material weakness in internal controls over inventory costing that will require restatement of previously issued financial statements, and reclassified $10.5M of related-party debt/credit lines from long-term to current, signaling near-term liquidity pressure.
Red Flags Detected (9)
Material weakness in internal controls over inventory/COGS accounting requiring restatement of prior financial statements
Management explicitly stated previously issued financial statements 'should no longer be relied upon'
Net income swung to net loss both quarter-over-quarter and six-month periods (from $3.2M/$3.6M income to losses of $(0.2)M/$(1.1)M)
6 more red flags detected
Key Takeaways
Company transitioned from profitability to losses in both Q2 and H1 2026 comparisons
Restatement of prior period financials is likely, creating uncertainty about historical reported results
3 more takeaways
Filing Overview
What This Means
High Risk Filing: This company is showing signs of financial stress or significant operational challenges.
Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.
Quarterly Report: Interim filing with unaudited financial data for the quarter.